ASGT Annual Meeting

Program

ASGT 6th Annual Meeting
June 4-8, 2003, Washington, D.C.
Jointly sponsored by Baylor College of Medicine, Houston, Texas

Program Schedule

Saturday, June 7
7:00 am - Noon	Poster Setup by Authors
7:30 am - 5:00 pm	Attendee Registration Open
8:00 am - 10:00 am	Scientific Symposia
	SS400 - Cancer: Clinical Trials Salon 2/3 Chair James Barsoum, PhD Speakers James Barsoum, PhD - Anti-Tumor Activity of Adenovirus-mediated Interferon-beta Gene Transfer Patricia Keegan, MD - Drug Development Programs for Gene Therapy Treatment of Cancer: Regulatory Considerations F. Stephen Hodi, MD - Augmentation of Gm-CSF-Based Vaccines Mirjana Urosevic, MD - Clinical Outcome of Cutaneous TCeu Lymphoma Patients Treated with TG1042-Adenovirus-interferon-Gamma
	SS401 - Ethics: Ethical and Policy Dilemmas in Clinical Gene Therapy Studies: Balancing Real Benefits Washington Room 5/6 Chair Theodore Friedmann, MD Speakers Marina Cavazzana-Calvo, MD, PhD - Haploidentical Hematopoietic Stem Cell Transplantation Versus Gene Therapy for X-SCID Patients: Current State Adrian J. Thrasher, MD, PhD - Gene Therapy for X-SCID Using a Galv-Pseudotyped Retroviral Vector Philip D. Noguchi, MD - Risk and Benefits: A Dynamic Balance Theodore Friedmann, MD - RAC and the NIH Guidelines - How Do We Approach Predictable Risks in the Face of Actual Benefit?
	SS402 - Genetic Diseases: Diabetes, Obesity and Related Disorders Salon 1 Chair Andrew F. Stewart, MD Speakers Andrew F. Stewart, MD - Hepatocyte Growth Factor Gene Therapy for Islet Transplantation Fatima Bosch, PhD - Gene Therapy Approaches to Counteract Diabetic Hyperglycemia Christopher B. Newgard, PhD - Genetic Engineering to Define Targets for Diabetes and Obesity Therapies Robert M. O'Doherty, PhD - Obesity: It's All in the Fat
	SS403 - Infectious Disease: Recent Trends in Biodefense: Genetically Modified Organisms and Gene Therapy Vectors Cotillion North & South Chair Margaret A. Liu, MD Speakers Andrew Ellington, PhD - Aptamers as Gene Therapy Reagents Gary J. Nabel, MD, PhD - Gene-Based Vaccines for Biodefense: Viral Hemorrhagic Fevers Bernard Moss, MD, PhD - Safer Smallpox Vaccines Captain Darrell R. Galloway, PhD - Gene-Based Vaccines for Biodefense: Anthrax
	SS404 - Non-Viral: Prospects for Non-Viral Mediated Gene Therapy Maryland Chair Leaf Huang, PhD Speakers Leaf Huang, PhD - Recent Advances in Non-Viral Gene Delivery Jon Wolff, MD - Non-Viral vs. Viral Vector Dichotomy: A Reappraisal David Cheresh, PhD - Vascular Targeted Gene Therapy Douglas Losordo, MD - VEGF Gene Therapy for Myocardial Ischemia and Diabetic Neuropothy
10:00 am - 10:15 am	Break
10:15 pm - 12:15 pm	Simultaneous Oral Presentations
	OA410 - Infectious Diseases and Vaccines Washington Room 2 Moderators K. Reed Clark, PhD Philip Johnson, MD (Abstracts #805 - #812)
	OA411 - Oncolytic Virus and Suicide Gene Therapy for Cancer Cotillion North and South Moderators Simon Hall, MD Ronald Rodriguez, MD, PhD (Abstracts #813 - #820)
	OA412 - Gene Therapy for the Nervous System I Maryland Moderators Krys Bankiewicz, MD, PhD Beverly L. Davidson, PhD (Abstracts #821 - #828)
	OA413 - Gene Therapy of Muscle Diseases Wilson Moderators Paula Clemens, MD Dongsheng Duan, PhD (Abstracts #829 - #836)
	OA414 - Molecular Conjugates Virginia Moderators Kam W. Leong, PhD Dan Luo, PhD (Abstracts #837 - #844)
	OA415 - Gene Regulation: Cell Therapies and Animal Models Marriott Ballroom Salon 2/3 Moderators David W. Emery, PhD Kyriacos A. Mitrophanous, PhD (Abstracts #845 - #852)
	OA416 - Cardiovascular I Washington Room 4 Moderator Margaret Samyn, MD (Abstracts #853 - #860)
Noon - 7:00 pm	Poster Viewing
12:30 pm - 1:30 pm	Meet-the-Expert Lunches The Meet-the-Expert sessions are designed to provide an opportunity for participants to interact with experts and discuss topics related to their research. A lunch will be served during the program, which will begin at 12:30 pm and last for approximately one hour. The Meet-the-Expert sessions require tickets for admission. Tickets for these sessions are not included in the regular registration fees to attend the meeting. Ushers will be collecting tickets at the door of each session. Tickets are available at the registration desk. Please note that space is limited.
	ME420 - Large Animal Models for Stem Cell Gene Therapy Optimization and Analysis of Vector Insertion Site Park Tower Room 8210 Cynthia Dunbar, MD
	ME421 - Drug Resistance Gene Therapy to Select Stem Cells Park Tower Room 8212 Stanton L. Gerson, MD
	ME422 - Gene Therapy Using Hemopoietic Stem Cells Johnson Room Donald B. Kohn, MD
	ME423 - Lentiviral Vectors: Current Challenges Park Tower Room 8219 Luigi Naldini, MD, PhD
	ME424 - Why Don't AAV Vectors Work in Every Cell Type? Harding Room Arun Srivastava, PhD
	ME425 - Gene Therapy for Metabolic Disorders Coolidge Room Chester B. Whitley, PhD, MD
	ME426 - Adenovirus Vector Targeting Hoover Room Thomas Wickham, PhD
1:30 pm - 4:15 pm	Presidential Symposium Chair Joseph Glorioso, PhD - Presidential Address Speakers Robert A. Weinberg, PhD - Rules Governing the Formation of Human Cancer Cells Donald B. Kohn, MD - Report From the ASGT Ad Hoc Committee on Retroviral-Mediated Gene Transfer to Hematopoietic Stem Cells Marina Cavazzana-Calvo, MD, PhD - SCID-X1 Clinical Trial: Current State Presentation of Top Three Abstracts #861 #862 #863
3:00 pm - 7:00 pm	Exhibit Hall Open
4:00 pm - 7:00 pm	Poster Session III Poster Session, Exhibits and Networking Reception Halls B/C RNA Virus Vectors III (Abstracts #864 through #889) Viral Production and Novel Vector Strategies (Abstracts #890 through #914) Cancer Therapy (Abstracts #915 through #946) Other DNA Viruses (Abstracts #947 through #963) Mechanistic Studies and Targeted Delivery (Abstracts #964 through #978) Naked DNA: Applications (Abstracts #979 through # 998) Genetic and Metabolic Diseases: Part II (Abstracts #999 through #1029) Gene Therapy for Bone, Connective Tissue and Skin Tissues (Abstracts #1030 through #1052) Stem Cell Gene Therapy for Genetic Diseases (Abstracts #1053 through #1072) Cancer Apoptosis (Abstracts #1073 through #1097) Cancer Targeted Gene Therapy III (Abstracts #1098 through #1126) Gene Regulation: Promoter and Construct Design (Abstracts #1127 through #1156)